because it is not a pharmacy medicine YET
The final decision by the delegate to make Astodrimer sodium nasal spray schedule 2 is sometime after today when final submissions close. A chance for us to say we support the interim decision and then he/she considers final submissions. In the interim decision 1 June was mentioned for potential pharmacy. SPL is not going to excite the market about interim decisions but I hope they have commenced Australian Therapeutic Goods Register ATGR application for Viraleze and with final decision the market notification is made
because it is not a pharmacy medicine YETThe final decision by...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.0¢ | $20.24K | 175.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 267920 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 192261 | 10 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.0¢ |
Change
-0.005 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 11.5¢ | 11.8¢ | 11.0¢ | 32412 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| SPL (ASX) Chart |